Participate in Research      Email list for events
I prefer to be contacted by:  Phone      Email
What is the best time to contact you?: 
 
  Research Site Selection Criteria

Genetic Components of Autism and Related Disorders

Linda Brzustowicz (PI)
Judy Flax (Co-I)
[Rutgers University]

brzustowicz@biology.rutgers.edu
(848) 445-3331

145 Bevier Road
Piscataway, NJ 08854

Families are encouraged to participate if they:

  • Have at least one family member with an autism spectrum disorder and language impairment 
  • Have at least one other family member with a language-based learning disability
  • Have at least 5 participating family members that speak English
  • Have all family members willing to give a blood sample for genetic analysis

Paratransit Travel and Mobility Assessment

Cecilia Feeley (PI)
[Rutgers University]

cfeeley@rci.rutgers.edu
(848) 445-2975

100 Brett Road
Piscataway, NJ 08854

  • Do you have autism spectrum disorder?
  • Are you 18 years or older?
  • Do you live in New Jersey?
  • Would you be interested in riding  Access Link or other county paratransit  services if you could? 

Can video speak the language of Autism?

Amy Learmonth (PI)
[William Paterson University]

learmontha@wpunj.edu
(973) 720-2765

300 Pompton Road
Wayne, NJ 07470

We are testing both typically developing children and children with Autism between the ages of 36 and 48 months.
https://www.youtube.com/v/_PoD6bJ6pIk 


Failed to Upload Picture

Sulforaphane in autism.

William Johnson (PI)
Edward (Scot) Strenos (Proj Coord)
[Rutgers University]

stenroos@rutgers.edu
(732) 235-5490

661 Hoes Lane West
Piscataway, NJ 08854

  • Males ages 13-30 years of age with Autistic Disorder diagnosis.

Using SMART Treatment Design to Evaluate ABA Interventions

Mary Louise E. Kerwin (PI)
Michelle Soreth (Co-PI)
[Rowan University]

kerwin@rowan.edu
(856) 256-4821

201 Mullica Hill Road
Glassboro, NJ 08028

Inclusion Criteria

  1. Previous clinical diagnosis of ASD based on DSM-V which is confirmed via scores on ADOS-2.
  2. Between the ages of 2 and 5 years.
  3. Receptive language age of at least 12 months on the MSEL
  4. Minimum of at least 2 spoken words during the administration of the ADOS-2
  5. Parent/guardian is willing to transport the child to intervention sessions at Rowan University
  6. English Speaking
  7. Parent/Guardian agrees not to start any new therapies during the 4 months of the study without speaking to PI first
  8. Parent/Guardian is willing to allow therapist-child and novel adult-child interaction assessment sessions to be video recorded and to complete assessment batteries at 8-weeks and 4-months.

Exclusion Criteria

  1. Medical histories and/or physical examination indicating physical or sensory impairments or significant medical problems (e.g., seizure disorders) that would interfere with learning.
  2. Exhibits severe aggression or self-injurious behavior

Failed to Upload Picture

Experiences of families of children newly diagnosed with ASD

Deborah Spitalnik (PI)
Caroline Coffield (Co-I)
[Boggs Center for Developmental Disabilities ]

deborah.spitalnik@rutgers.edu
(732) 235-9326

335 George Street
New Brunswick, NJ 08902

Latino families of children newly diagnosed with ASD


  • English or Spanish speaking
  •  with a child between the ages of 18 months and 5 years

Development of Early Markers of ASD

Michael Lewis (PI)
Nicholas Minar (Co-I)
[Rutgers University]

lewis@rwjms.rutgers.edu
(732) 235-7700

89 French Street
New Brunswick, NJ 08901

Infants and toddlers between the ages of 3 months and 24 months

  • typically developing or
  • at-risk (older sibling diagnosed with ASD)

Failed to Upload Picture

Bridging behavior and genetics

Elizabeth Torres (PI)
Caroline Whyatt (Co-PI)
[Rutgers University]

ebtorres@rci.rutgers.edu
(848) 445-8909

152 Frelinghuysen Rd
Piscataway, NJ 08854

  • individuals with autism and their immediate family members
  • individuals with autism related to the Fragile-X mental retardation gene FMR1, both individuals with a diagnosis of autism with the full mutation (Fragile-X syndrome, FXS) and those who are carriers
  • neurotypical individuals and their family members

Doctors Jyonouchi (standing) and Lee (seated)

Autism Spectrum Disorder-Inflammatory Subtype: Biomarker Analysis

Harumi Jyonouchi (PI)
[Saint Peter's University Hospital]

hjyonouchi@saintpetersuh.com
(732) 339-7780

254 Easton Avenue, 3rd Floor MOB
New Brunswick, NJ 08901

  • ASD subjects diagnosed within 12 mo (Age 2-6 years)
  • ASD subjects with established ASD diagnosis (Age 7-31 years)

Failed to Upload Picture

Autism and the Built Environment: Evaluating the Physiological and Biomedical Effects of Pedestrian Infrastructure Design and Road Crossing Behavior of Adults on the Autism Spectrum

Cecilia Feeley (PI)
Caroline Whyatt (Co-PI)
[Rutgers University]

cfeeley@rci.rutgers.edu
(848) 445-2975

100 Brett Road
Piscataway, NJ 08854

The research team will evaluate the physiological and biomedical impacts of the pedestrian infrastructure system in New Jersey onto adults on the autism spectrum as compared to the control group. Through a series of physiological and biomedical impacts when viewing pedestrian infrastructure in the following environment in a series of 2 dimensional and digitally recorded real world road crossing scenarios.